Announcements Trials
Browse Landscape

Phase

Phase 2 108Phase 3 57Phase 1 40Phase 1/2 28Phase 2/3 7Phase NA 3

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Pancreatic Neoplasms 2Thromboembolism 1Non-small Cell Lung Cancer Metastatic 1

Interventions

Standard of Care 177Blood Specimen Collection 138Exercise 123Educational Status 114Methods 109Interviews as Topic 106Practice Guidelines as Topic 105Surveys and Questionnaires 104Early Intervention, Educational 93Magnetic Resonance Spectroscopy 80Specimen Handling 78Radiosurgery 68Radiotherapy 56Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 34Resistance Training 32Drug Therapy 32Therapeutics 31Surgical Procedures, Operative 31Diet Therapy 30Counseling 29Behavior Therapy 29Acupuncture Therapy 25Proton Therapy 24Nutrition Assessment 24Exercise Test 24Magnetic Resonance Imaging 23Radiation 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × 130-nm albumin-bound paclitaxel × 1 year × Clear all
NCT05407155 2026-04-23

BETTER

Fudan University

Phase NA Active not recruiting
56 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT04894643 2026-03-20

PARC

EBG MedAustron GmbH

Phase NA Recruiting
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02921022 2025-11-26

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
110 enrolled
Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡